SCHEMBL7521872

SCHEMBL7521872

CC(C)(C)c1cc(-n2nc3ccccc3n2)c(O)c(C(C)(c2ccc(OCCN3C(=O)c4ccccc4C3=O)cc2)c2ccc(OCCN3C(=O)c4ccccc4C3=O)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RAB9A P51151 7/20 0.45
TDP1 Q9NUW8 4/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
NPC1 O15118 3/20 0.43
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.40
APEX1 P27695 1/20 0.40
HSD17B10 Q99714 1/20 0.40
USP2 O75604 1/20 0.39
CXCR5 P32302 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860452 0.94 HPGD (0.47) HPGDNPSR1RAB9ATDP1MAPT
SCHEMBL7521571 0.85 SMN1; SMN2 (0.38) HPGDRAB9ATDP1MAPTALDH1A1
SCHEMBL7655370 0.84 NPC1 (0.36) HPGDNPSR1RAB9ATDP1MAPT
SCHEMBL7516817 0.80 HTT (0.45) RAB9ATDP1MAPTALDH1A1NPC1
SCHEMBL6862331 0.79 SMN1; SMN2 (0.38) HPGDNPSR1RAB9ATDP1MAPT
SCHEMBL6861261 0.78 NPC1 (0.36) HPGDNPSR1RAB9ATDP1MAPT
SCHEMBL7519989 0.77 NPC1 (0.45) HPGDRAB9ATDP1MAPTALDH1A1
SCHEMBL4902431 0.76 HPGD (0.73) HPGDNPSR1RAB9ATDP1MAPT
SCHEMBL672017 0.74 MEN1 (0.39) HPGDRAB9AMAPTALDH1A1NPC1
SCHEMBL31267542 0.74 MEN1 (0.39) HPGDRAB9AMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH HPGD 2489/4885NPSR1 4814/4885RAB9A 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.